US Patent 10125361 Compositions and methods of nucleic acid-targeting nucleic acids

Is a

Patent

Patent attributes

Patent Applicant

Caribou Biosciences

Current Assignee

Caribou Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101253610

Patent Inventor Names

Rachel E. Haurwitz0

Jennifer A. Doudna0

Matthew Merrill Carter0

Paul Daniel Donohoue0

Andrew Paul May0

James M. Berger0

Date of Patent

November 13, 2018

Patent Application Number

151597760

Date Filed

May 19, 2016

Patent Citations Received

‌

US Patent 12110545 Methods of assessing nuclease cleavage

‌

US Patent 11661599 CRISPR-Cas based system for targeting single-stranded sequences

‌

US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing

‌

US Patent 11390884 Optimized CRISPR/cas9 systems and methods for gene editing in stem cells

‌

US Patent 11421228 Gene-regulating compositions and methods for improved immunotherapy

‌

US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites

‌

US Patent 11911415 CRISPR/Cas-related methods and compositions for improving transplantation

‌

US Patent 11952571 Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)

...

Patent Primary Examiner

‌

James S Ketter

Patent abstract

This disclosure provides for compositions and methods for the use of nucleic acid-targeting nucleic acids and complexes thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10125361 Compositions and methods of nucleic acid-targeting nucleic acids

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10125361 Compositions and methods of nucleic acid-targeting nucleic acids